BIGGER CAPITAL FUND L P → Dermata Therapeutics, Inc. DRMA

Stake: — Shares: — Class: Common Stock, $0.0001 par value

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

77,279 shares short · -8.5% vs prior

Other 13D/G Filings on Dermata Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-01	SCHEDULE 13D	Van Hoose Kyri K.	9.00%	384,352	view →
2026-01-08	SCHEDULE	PROEHL GERALD T	24.70%	694,530	view →
2025-04-03	SCHEDULE	PROEHL GERALD T	7.80%	804,098	view →
2025-02-13	SCHEDULE	PROEHL GERALD T	15.00%	803,751	view →
2025-01-23	SCHEDULE	PROEHL GERALD T	16.00%	803,751	view →

Other Filings by BIGGER CAPITAL FUND L P

Filed	Form	Issuer	Stake	Shares
2026-07-02	SCHEDULE 13G	BTC Digital Ltd. BTCT	—	—	view →
2026-05-21	SCHEDULE 13G	Sunshine Biopharma Inc. SBFMW	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →